nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4D—hypertension	0.33	0.515	CbGaD
Roflumilast—PDE4A—hypertension	0.311	0.485	CbGaD
Roflumilast—PDE4C—brainstem—hypertension	0.0012	0.109	CbGeAlD
Roflumilast—PDE4D—heart—hypertension	0.000914	0.0832	CbGeAlD
Roflumilast—PDE4D—cortex of kidney—hypertension	0.000822	0.0748	CbGeAlD
Roflumilast—PDE4A—heart—hypertension	0.000809	0.0736	CbGeAlD
Roflumilast—PDE4A—decidua—hypertension	0.000787	0.0716	CbGeAlD
Roflumilast—PDE4B—cardiac ventricle—hypertension	0.000735	0.0668	CbGeAlD
Roflumilast—PDE4B—myocardium—hypertension	0.000691	0.0629	CbGeAlD
Roflumilast—PDE4D—adrenal gland—hypertension	0.000682	0.0621	CbGeAlD
Roflumilast—PDE4C—central nervous system—hypertension	0.000606	0.0551	CbGeAlD
Roflumilast—PDE4A—adrenal gland—hypertension	0.000604	0.0549	CbGeAlD
Roflumilast—PDE4B—heart—hypertension	0.000482	0.0439	CbGeAlD
Roflumilast—PDE4B—decidua—hypertension	0.000469	0.0427	CbGeAlD
Roflumilast—PDE4B—cortex of kidney—hypertension	0.000434	0.0395	CbGeAlD
Roflumilast—PDE4B—cardiac atrium—hypertension	0.000412	0.0375	CbGeAlD
Roflumilast—PDE4B—medulla oblongata—hypertension	0.000389	0.0354	CbGeAlD
Roflumilast—PDE4B—adrenal gland—hypertension	0.00036	0.0328	CbGeAlD
Roflumilast—PDE4B—endocrine gland—hypertension	0.000312	0.0284	CbGeAlD
Roflumilast—PDE4B—central nervous system—hypertension	0.000281	0.0256	CbGeAlD
Roflumilast—Dizziness—Verapamil—hypertension	6.03e-05	0.000263	CcSEcCtD
Roflumilast—Constipation—Betaxolol—hypertension	6.02e-05	0.000263	CcSEcCtD
Roflumilast—Feeling abnormal—Irbesartan—hypertension	6.01e-05	0.000262	CcSEcCtD
Roflumilast—Headache—Diltiazem—hypertension	6.01e-05	0.000262	CcSEcCtD
Roflumilast—Headache—Indapamide—hypertension	6.01e-05	0.000262	CcSEcCtD
Roflumilast—Myalgia—Timolol—hypertension	6e-05	0.000262	CcSEcCtD
Roflumilast—Rash—Carvedilol—hypertension	5.99e-05	0.000261	CcSEcCtD
Roflumilast—Gastrointestinal pain—Perindopril—hypertension	5.98e-05	0.000261	CcSEcCtD
Roflumilast—Dermatitis—Carvedilol—hypertension	5.98e-05	0.000261	CcSEcCtD
Roflumilast—Anxiety—Timolol—hypertension	5.98e-05	0.000261	CcSEcCtD
Roflumilast—Angioedema—Lisinopril—hypertension	5.97e-05	0.000261	CcSEcCtD
Roflumilast—Vomiting—Doxazosin—hypertension	5.97e-05	0.00026	CcSEcCtD
Roflumilast—Decreased appetite—Losartan—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Gastrointestinal pain—Irbesartan—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Feeling abnormal—Hydrochlorothiazide—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Hypersensitivity—Clonidine—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Abdominal pain—Captopril—hypertension	5.96e-05	0.00026	CcSEcCtD
Roflumilast—Headache—Carvedilol—hypertension	5.95e-05	0.00026	CcSEcCtD
Roflumilast—Discomfort—Timolol—hypertension	5.93e-05	0.000259	CcSEcCtD
Roflumilast—Rash—Doxazosin—hypertension	5.92e-05	0.000258	CcSEcCtD
Roflumilast—Fatigue—Losartan—hypertension	5.92e-05	0.000258	CcSEcCtD
Roflumilast—Dermatitis—Doxazosin—hypertension	5.92e-05	0.000258	CcSEcCtD
Roflumilast—Gastrointestinal pain—Hydrochlorothiazide—hypertension	5.91e-05	0.000258	CcSEcCtD
Roflumilast—Vomiting—Fosinopril—hypertension	5.9e-05	0.000257	CcSEcCtD
Roflumilast—Malaise—Lisinopril—hypertension	5.9e-05	0.000257	CcSEcCtD
Roflumilast—Nausea—Propranolol—hypertension	5.88e-05	0.000257	CcSEcCtD
Roflumilast—Headache—Doxazosin—hypertension	5.88e-05	0.000257	CcSEcCtD
Roflumilast—Vertigo—Lisinopril—hypertension	5.87e-05	0.000256	CcSEcCtD
Roflumilast—Constipation—Losartan—hypertension	5.87e-05	0.000256	CcSEcCtD
Roflumilast—Vomiting—Eplerenone—hypertension	5.86e-05	0.000256	CcSEcCtD
Roflumilast—Feeling abnormal—Furosemide—hypertension	5.86e-05	0.000256	CcSEcCtD
Roflumilast—Rash—Fosinopril—hypertension	5.85e-05	0.000255	CcSEcCtD
Roflumilast—Dermatitis—Fosinopril—hypertension	5.84e-05	0.000255	CcSEcCtD
Roflumilast—Vomiting—Nifedipine—hypertension	5.82e-05	0.000254	CcSEcCtD
Roflumilast—Gastrointestinal pain—Furosemide—hypertension	5.81e-05	0.000254	CcSEcCtD
Roflumilast—Rash—Eplerenone—hypertension	5.81e-05	0.000254	CcSEcCtD
Roflumilast—Urticaria—Perindopril—hypertension	5.81e-05	0.000254	CcSEcCtD
Roflumilast—Headache—Fosinopril—hypertension	5.81e-05	0.000254	CcSEcCtD
Roflumilast—Hypersensitivity—Trandolapril—hypertension	5.81e-05	0.000254	CcSEcCtD
Roflumilast—Dermatitis—Eplerenone—hypertension	5.81e-05	0.000253	CcSEcCtD
Roflumilast—Diarrhoea—Valsartan—hypertension	5.8e-05	0.000253	CcSEcCtD
Roflumilast—Asthenia—Clonidine—hypertension	5.8e-05	0.000253	CcSEcCtD
Roflumilast—Feeling abnormal—Betaxolol—hypertension	5.8e-05	0.000253	CcSEcCtD
Roflumilast—Vomiting—Verapamil—hypertension	5.79e-05	0.000253	CcSEcCtD
Roflumilast—Urticaria—Irbesartan—hypertension	5.79e-05	0.000253	CcSEcCtD
Roflumilast—Hypersensitivity—Enalapril—hypertension	5.79e-05	0.000253	CcSEcCtD
Roflumilast—Abdominal pain—Perindopril—hypertension	5.78e-05	0.000252	CcSEcCtD
Roflumilast—Palpitations—Lisinopril—hypertension	5.78e-05	0.000252	CcSEcCtD
Roflumilast—Diarrhoea—Olmesartan—hypertension	5.78e-05	0.000252	CcSEcCtD
Roflumilast—Headache—Eplerenone—hypertension	5.78e-05	0.000252	CcSEcCtD
Roflumilast—Rash—Nifedipine—hypertension	5.77e-05	0.000252	CcSEcCtD
Roflumilast—Nervous system disorder—Ramipril—hypertension	5.77e-05	0.000252	CcSEcCtD
Roflumilast—Dermatitis—Nifedipine—hypertension	5.77e-05	0.000252	CcSEcCtD
Roflumilast—Abdominal pain—Irbesartan—hypertension	5.76e-05	0.000251	CcSEcCtD
Roflumilast—Rash—Verapamil—hypertension	5.75e-05	0.000251	CcSEcCtD
Roflumilast—Urticaria—Hydrochlorothiazide—hypertension	5.74e-05	0.000251	CcSEcCtD
Roflumilast—Dermatitis—Verapamil—hypertension	5.74e-05	0.00025	CcSEcCtD
Roflumilast—Headache—Nifedipine—hypertension	5.73e-05	0.00025	CcSEcCtD
Roflumilast—Abdominal pain—Hydrochlorothiazide—hypertension	5.72e-05	0.000249	CcSEcCtD
Roflumilast—Skin disorder—Ramipril—hypertension	5.71e-05	0.000249	CcSEcCtD
Roflumilast—Infection—Timolol—hypertension	5.71e-05	0.000249	CcSEcCtD
Roflumilast—Headache—Verapamil—hypertension	5.71e-05	0.000249	CcSEcCtD
Roflumilast—Hypersensitivity—Telmisartan—hypertension	5.71e-05	0.000249	CcSEcCtD
Roflumilast—Nausea—Diltiazem—hypertension	5.7e-05	0.000248	CcSEcCtD
Roflumilast—Nausea—Indapamide—hypertension	5.7e-05	0.000248	CcSEcCtD
Roflumilast—Asthenia—Trandolapril—hypertension	5.66e-05	0.000247	CcSEcCtD
Roflumilast—Feeling abnormal—Losartan—hypertension	5.65e-05	0.000247	CcSEcCtD
Roflumilast—Urticaria—Furosemide—hypertension	5.65e-05	0.000246	CcSEcCtD
Roflumilast—Nervous system disorder—Timolol—hypertension	5.64e-05	0.000246	CcSEcCtD
Roflumilast—Nausea—Carvedilol—hypertension	5.64e-05	0.000246	CcSEcCtD
Roflumilast—Asthenia—Enalapril—hypertension	5.64e-05	0.000246	CcSEcCtD
Roflumilast—Abdominal pain—Furosemide—hypertension	5.62e-05	0.000245	CcSEcCtD
Roflumilast—Gastrointestinal pain—Losartan—hypertension	5.61e-05	0.000245	CcSEcCtD
Roflumilast—Dizziness—Valsartan—hypertension	5.61e-05	0.000245	CcSEcCtD
Roflumilast—Urticaria—Betaxolol—hypertension	5.59e-05	0.000244	CcSEcCtD
Roflumilast—Skin disorder—Timolol—hypertension	5.59e-05	0.000244	CcSEcCtD
Roflumilast—Dizziness—Olmesartan—hypertension	5.58e-05	0.000244	CcSEcCtD
Roflumilast—Nausea—Doxazosin—hypertension	5.58e-05	0.000243	CcSEcCtD
Roflumilast—Myalgia—Lisinopril—hypertension	5.57e-05	0.000243	CcSEcCtD
Roflumilast—Asthenia—Telmisartan—hypertension	5.56e-05	0.000243	CcSEcCtD
Roflumilast—Anxiety—Lisinopril—hypertension	5.55e-05	0.000242	CcSEcCtD
Roflumilast—Diarrhoea—Clonidine—hypertension	5.53e-05	0.000241	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.53e-05	0.000241	CcSEcCtD
Roflumilast—Nausea—Fosinopril—hypertension	5.51e-05	0.00024	CcSEcCtD
Roflumilast—Discomfort—Lisinopril—hypertension	5.5e-05	0.00024	CcSEcCtD
Roflumilast—Nausea—Eplerenone—hypertension	5.48e-05	0.000239	CcSEcCtD
Roflumilast—Urticaria—Losartan—hypertension	5.45e-05	0.000238	CcSEcCtD
Roflumilast—Nausea—Nifedipine—hypertension	5.44e-05	0.000237	CcSEcCtD
Roflumilast—Abdominal pain—Losartan—hypertension	5.42e-05	0.000237	CcSEcCtD
Roflumilast—Nausea—Verapamil—hypertension	5.41e-05	0.000236	CcSEcCtD
Roflumilast—Asthenia—Captopril—hypertension	5.41e-05	0.000236	CcSEcCtD
Roflumilast—Diarrhoea—Trandolapril—hypertension	5.4e-05	0.000235	CcSEcCtD
Roflumilast—Vomiting—Valsartan—hypertension	5.39e-05	0.000235	CcSEcCtD
Roflumilast—Diarrhoea—Enalapril—hypertension	5.37e-05	0.000234	CcSEcCtD
Roflumilast—Hypersensitivity—Irbesartan—hypertension	5.37e-05	0.000234	CcSEcCtD
Roflumilast—Vomiting—Olmesartan—hypertension	5.37e-05	0.000234	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Ramipril—hypertension	5.36e-05	0.000234	CcSEcCtD
Roflumilast—Rash—Valsartan—hypertension	5.35e-05	0.000233	CcSEcCtD
Roflumilast—Dizziness—Clonidine—hypertension	5.35e-05	0.000233	CcSEcCtD
Roflumilast—Dermatitis—Valsartan—hypertension	5.34e-05	0.000233	CcSEcCtD
Roflumilast—Hypersensitivity—Hydrochlorothiazide—hypertension	5.33e-05	0.000232	CcSEcCtD
Roflumilast—Rash—Olmesartan—hypertension	5.32e-05	0.000232	CcSEcCtD
Roflumilast—Insomnia—Ramipril—hypertension	5.32e-05	0.000232	CcSEcCtD
Roflumilast—Dermatitis—Olmesartan—hypertension	5.32e-05	0.000232	CcSEcCtD
Roflumilast—Headache—Valsartan—hypertension	5.31e-05	0.000232	CcSEcCtD
Roflumilast—Diarrhoea—Telmisartan—hypertension	5.3e-05	0.000231	CcSEcCtD
Roflumilast—Infection—Lisinopril—hypertension	5.3e-05	0.000231	CcSEcCtD
Roflumilast—Headache—Olmesartan—hypertension	5.29e-05	0.000231	CcSEcCtD
Roflumilast—Asthenia—Perindopril—hypertension	5.25e-05	0.000229	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Timolol—hypertension	5.24e-05	0.000229	CcSEcCtD
Roflumilast—Hypersensitivity—Furosemide—hypertension	5.24e-05	0.000229	CcSEcCtD
Roflumilast—Asthenia—Irbesartan—hypertension	5.23e-05	0.000228	CcSEcCtD
Roflumilast—Dizziness—Trandolapril—hypertension	5.22e-05	0.000228	CcSEcCtD
Roflumilast—Insomnia—Timolol—hypertension	5.2e-05	0.000227	CcSEcCtD
Roflumilast—Dizziness—Enalapril—hypertension	5.19e-05	0.000227	CcSEcCtD
Roflumilast—Asthenia—Hydrochlorothiazide—hypertension	5.19e-05	0.000226	CcSEcCtD
Roflumilast—Hypersensitivity—Betaxolol—hypertension	5.19e-05	0.000226	CcSEcCtD
Roflumilast—Skin disorder—Lisinopril—hypertension	5.18e-05	0.000226	CcSEcCtD
Roflumilast—Dyspepsia—Ramipril—hypertension	5.18e-05	0.000226	CcSEcCtD
Roflumilast—Diarrhoea—Captopril—hypertension	5.15e-05	0.000225	CcSEcCtD
Roflumilast—Vomiting—Clonidine—hypertension	5.14e-05	0.000224	CcSEcCtD
Roflumilast—Dizziness—Telmisartan—hypertension	5.12e-05	0.000224	CcSEcCtD
Roflumilast—Decreased appetite—Ramipril—hypertension	5.11e-05	0.000223	CcSEcCtD
Roflumilast—Asthenia—Furosemide—hypertension	5.1e-05	0.000223	CcSEcCtD
Roflumilast—Rash—Clonidine—hypertension	5.1e-05	0.000222	CcSEcCtD
Roflumilast—Dermatitis—Clonidine—hypertension	5.09e-05	0.000222	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Ramipril—hypertension	5.08e-05	0.000222	CcSEcCtD
Roflumilast—Fatigue—Ramipril—hypertension	5.07e-05	0.000221	CcSEcCtD
Roflumilast—Headache—Clonidine—hypertension	5.07e-05	0.000221	CcSEcCtD
Roflumilast—Dyspepsia—Timolol—hypertension	5.06e-05	0.000221	CcSEcCtD
Roflumilast—Hypersensitivity—Losartan—hypertension	5.06e-05	0.000221	CcSEcCtD
Roflumilast—Asthenia—Betaxolol—hypertension	5.05e-05	0.00022	CcSEcCtD
Roflumilast—Nausea—Valsartan—hypertension	5.04e-05	0.00022	CcSEcCtD
Roflumilast—Constipation—Ramipril—hypertension	5.03e-05	0.000219	CcSEcCtD
Roflumilast—Nausea—Olmesartan—hypertension	5.01e-05	0.000219	CcSEcCtD
Roflumilast—Vomiting—Trandolapril—hypertension	5.01e-05	0.000219	CcSEcCtD
Roflumilast—Diarrhoea—Perindopril—hypertension	5e-05	0.000218	CcSEcCtD
Roflumilast—Decreased appetite—Timolol—hypertension	5e-05	0.000218	CcSEcCtD
Roflumilast—Vomiting—Enalapril—hypertension	4.99e-05	0.000218	CcSEcCtD
Roflumilast—Diarrhoea—Irbesartan—hypertension	4.99e-05	0.000218	CcSEcCtD
Roflumilast—Dizziness—Captopril—hypertension	4.98e-05	0.000217	CcSEcCtD
Roflumilast—Rash—Trandolapril—hypertension	4.97e-05	0.000217	CcSEcCtD
Roflumilast—Dermatitis—Trandolapril—hypertension	4.97e-05	0.000217	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Timolol—hypertension	4.97e-05	0.000217	CcSEcCtD
Roflumilast—Fatigue—Timolol—hypertension	4.96e-05	0.000216	CcSEcCtD
Roflumilast—Rash—Enalapril—hypertension	4.95e-05	0.000216	CcSEcCtD
Roflumilast—Dermatitis—Enalapril—hypertension	4.95e-05	0.000216	CcSEcCtD
Roflumilast—Diarrhoea—Hydrochlorothiazide—hypertension	4.95e-05	0.000216	CcSEcCtD
Roflumilast—Headache—Trandolapril—hypertension	4.94e-05	0.000216	CcSEcCtD
Roflumilast—Vomiting—Telmisartan—hypertension	4.93e-05	0.000215	CcSEcCtD
Roflumilast—Asthenia—Losartan—hypertension	4.92e-05	0.000215	CcSEcCtD
Roflumilast—Headache—Enalapril—hypertension	4.92e-05	0.000215	CcSEcCtD
Roflumilast—Rash—Telmisartan—hypertension	4.89e-05	0.000213	CcSEcCtD
Roflumilast—Dermatitis—Telmisartan—hypertension	4.88e-05	0.000213	CcSEcCtD
Roflumilast—Diarrhoea—Furosemide—hypertension	4.87e-05	0.000212	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Lisinopril—hypertension	4.86e-05	0.000212	CcSEcCtD
Roflumilast—Headache—Telmisartan—hypertension	4.85e-05	0.000212	CcSEcCtD
Roflumilast—Feeling abnormal—Ramipril—hypertension	4.85e-05	0.000212	CcSEcCtD
Roflumilast—Dizziness—Perindopril—hypertension	4.84e-05	0.000211	CcSEcCtD
Roflumilast—Insomnia—Lisinopril—hypertension	4.83e-05	0.000211	CcSEcCtD
Roflumilast—Dizziness—Irbesartan—hypertension	4.82e-05	0.00021	CcSEcCtD
Roflumilast—Diarrhoea—Betaxolol—hypertension	4.82e-05	0.00021	CcSEcCtD
Roflumilast—Gastrointestinal pain—Ramipril—hypertension	4.81e-05	0.00021	CcSEcCtD
Roflumilast—Nausea—Clonidine—hypertension	4.8e-05	0.00021	CcSEcCtD
Roflumilast—Vomiting—Captopril—hypertension	4.79e-05	0.000209	CcSEcCtD
Roflumilast—Dizziness—Hydrochlorothiazide—hypertension	4.78e-05	0.000209	CcSEcCtD
Roflumilast—Rash—Captopril—hypertension	4.75e-05	0.000207	CcSEcCtD
Roflumilast—Dermatitis—Captopril—hypertension	4.75e-05	0.000207	CcSEcCtD
Roflumilast—Feeling abnormal—Timolol—hypertension	4.74e-05	0.000207	CcSEcCtD
Roflumilast—Headache—Captopril—hypertension	4.72e-05	0.000206	CcSEcCtD
Roflumilast—Gastrointestinal pain—Timolol—hypertension	4.7e-05	0.000205	CcSEcCtD
Roflumilast—Dizziness—Furosemide—hypertension	4.7e-05	0.000205	CcSEcCtD
Roflumilast—Dyspepsia—Lisinopril—hypertension	4.7e-05	0.000205	CcSEcCtD
Roflumilast—Diarrhoea—Losartan—hypertension	4.69e-05	0.000205	CcSEcCtD
Roflumilast—Nausea—Trandolapril—hypertension	4.68e-05	0.000204	CcSEcCtD
Roflumilast—Urticaria—Ramipril—hypertension	4.67e-05	0.000204	CcSEcCtD
Roflumilast—Nausea—Enalapril—hypertension	4.67e-05	0.000204	CcSEcCtD
Roflumilast—Dizziness—Betaxolol—hypertension	4.66e-05	0.000203	CcSEcCtD
Roflumilast—Vomiting—Perindopril—hypertension	4.65e-05	0.000203	CcSEcCtD
Roflumilast—Abdominal pain—Ramipril—hypertension	4.65e-05	0.000203	CcSEcCtD
Roflumilast—Decreased appetite—Lisinopril—hypertension	4.64e-05	0.000202	CcSEcCtD
Roflumilast—Vomiting—Irbesartan—hypertension	4.64e-05	0.000202	CcSEcCtD
Roflumilast—Rash—Perindopril—hypertension	4.61e-05	0.000201	CcSEcCtD
Roflumilast—Dermatitis—Perindopril—hypertension	4.61e-05	0.000201	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Lisinopril—hypertension	4.61e-05	0.000201	CcSEcCtD
Roflumilast—Nausea—Telmisartan—hypertension	4.6e-05	0.000201	CcSEcCtD
Roflumilast—Fatigue—Lisinopril—hypertension	4.6e-05	0.000201	CcSEcCtD
Roflumilast—Vomiting—Hydrochlorothiazide—hypertension	4.6e-05	0.000201	CcSEcCtD
Roflumilast—Rash—Irbesartan—hypertension	4.6e-05	0.000201	CcSEcCtD
Roflumilast—Dermatitis—Irbesartan—hypertension	4.59e-05	0.0002	CcSEcCtD
Roflumilast—Headache—Perindopril—hypertension	4.58e-05	0.0002	CcSEcCtD
Roflumilast—Urticaria—Timolol—hypertension	4.57e-05	0.000199	CcSEcCtD
Roflumilast—Headache—Irbesartan—hypertension	4.57e-05	0.000199	CcSEcCtD
Roflumilast—Constipation—Lisinopril—hypertension	4.56e-05	0.000199	CcSEcCtD
Roflumilast—Rash—Hydrochlorothiazide—hypertension	4.56e-05	0.000199	CcSEcCtD
Roflumilast—Dermatitis—Hydrochlorothiazide—hypertension	4.56e-05	0.000199	CcSEcCtD
Roflumilast—Abdominal pain—Timolol—hypertension	4.55e-05	0.000198	CcSEcCtD
Roflumilast—Dizziness—Losartan—hypertension	4.54e-05	0.000198	CcSEcCtD
Roflumilast—Headache—Hydrochlorothiazide—hypertension	4.53e-05	0.000198	CcSEcCtD
Roflumilast—Vomiting—Furosemide—hypertension	4.52e-05	0.000197	CcSEcCtD
Roflumilast—Rash—Furosemide—hypertension	4.48e-05	0.000196	CcSEcCtD
Roflumilast—Dermatitis—Furosemide—hypertension	4.48e-05	0.000195	CcSEcCtD
Roflumilast—Vomiting—Betaxolol—hypertension	4.48e-05	0.000195	CcSEcCtD
Roflumilast—Nausea—Captopril—hypertension	4.48e-05	0.000195	CcSEcCtD
Roflumilast—Headache—Furosemide—hypertension	4.45e-05	0.000194	CcSEcCtD
Roflumilast—Rash—Betaxolol—hypertension	4.44e-05	0.000194	CcSEcCtD
Roflumilast—Dermatitis—Betaxolol—hypertension	4.43e-05	0.000193	CcSEcCtD
Roflumilast—Headache—Betaxolol—hypertension	4.41e-05	0.000192	CcSEcCtD
Roflumilast—Feeling abnormal—Lisinopril—hypertension	4.4e-05	0.000192	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lisinopril—hypertension	4.36e-05	0.00019	CcSEcCtD
Roflumilast—Vomiting—Losartan—hypertension	4.36e-05	0.00019	CcSEcCtD
Roflumilast—Nausea—Perindopril—hypertension	4.34e-05	0.00019	CcSEcCtD
Roflumilast—Hypersensitivity—Ramipril—hypertension	4.33e-05	0.000189	CcSEcCtD
Roflumilast—Nausea—Irbesartan—hypertension	4.33e-05	0.000189	CcSEcCtD
Roflumilast—Rash—Losartan—hypertension	4.33e-05	0.000189	CcSEcCtD
Roflumilast—Dermatitis—Losartan—hypertension	4.32e-05	0.000189	CcSEcCtD
Roflumilast—Headache—Losartan—hypertension	4.3e-05	0.000188	CcSEcCtD
Roflumilast—Nausea—Hydrochlorothiazide—hypertension	4.3e-05	0.000187	CcSEcCtD
Roflumilast—Urticaria—Lisinopril—hypertension	4.24e-05	0.000185	CcSEcCtD
Roflumilast—Hypersensitivity—Timolol—hypertension	4.24e-05	0.000185	CcSEcCtD
Roflumilast—Nausea—Furosemide—hypertension	4.22e-05	0.000184	CcSEcCtD
Roflumilast—Asthenia—Ramipril—hypertension	4.22e-05	0.000184	CcSEcCtD
Roflumilast—Abdominal pain—Lisinopril—hypertension	4.22e-05	0.000184	CcSEcCtD
Roflumilast—Nausea—Betaxolol—hypertension	4.18e-05	0.000182	CcSEcCtD
Roflumilast—Asthenia—Timolol—hypertension	4.13e-05	0.00018	CcSEcCtD
Roflumilast—Nausea—Losartan—hypertension	4.08e-05	0.000178	CcSEcCtD
Roflumilast—Diarrhoea—Ramipril—hypertension	4.03e-05	0.000176	CcSEcCtD
Roflumilast—Diarrhoea—Timolol—hypertension	3.94e-05	0.000172	CcSEcCtD
Roflumilast—Hypersensitivity—Lisinopril—hypertension	3.93e-05	0.000172	CcSEcCtD
Roflumilast—Dizziness—Ramipril—hypertension	3.89e-05	0.00017	CcSEcCtD
Roflumilast—Asthenia—Lisinopril—hypertension	3.83e-05	0.000167	CcSEcCtD
Roflumilast—Dizziness—Timolol—hypertension	3.8e-05	0.000166	CcSEcCtD
Roflumilast—Vomiting—Ramipril—hypertension	3.74e-05	0.000163	CcSEcCtD
Roflumilast—Rash—Ramipril—hypertension	3.71e-05	0.000162	CcSEcCtD
Roflumilast—Dermatitis—Ramipril—hypertension	3.71e-05	0.000162	CcSEcCtD
Roflumilast—Headache—Ramipril—hypertension	3.69e-05	0.000161	CcSEcCtD
Roflumilast—Vomiting—Timolol—hypertension	3.66e-05	0.00016	CcSEcCtD
Roflumilast—Diarrhoea—Lisinopril—hypertension	3.65e-05	0.000159	CcSEcCtD
Roflumilast—Rash—Timolol—hypertension	3.63e-05	0.000158	CcSEcCtD
Roflumilast—Dermatitis—Timolol—hypertension	3.62e-05	0.000158	CcSEcCtD
Roflumilast—Headache—Timolol—hypertension	3.6e-05	0.000157	CcSEcCtD
Roflumilast—Dizziness—Lisinopril—hypertension	3.53e-05	0.000154	CcSEcCtD
Roflumilast—Nausea—Ramipril—hypertension	3.49e-05	0.000152	CcSEcCtD
Roflumilast—Nausea—Timolol—hypertension	3.42e-05	0.000149	CcSEcCtD
Roflumilast—Vomiting—Lisinopril—hypertension	3.39e-05	0.000148	CcSEcCtD
Roflumilast—Rash—Lisinopril—hypertension	3.36e-05	0.000147	CcSEcCtD
Roflumilast—Dermatitis—Lisinopril—hypertension	3.36e-05	0.000147	CcSEcCtD
Roflumilast—Headache—Lisinopril—hypertension	3.34e-05	0.000146	CcSEcCtD
Roflumilast—Nausea—Lisinopril—hypertension	3.17e-05	0.000138	CcSEcCtD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3R1—hypertension	1.45e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EDN1—hypertension	1.45e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL5—hypertension	1.44e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—RHOA—hypertension	1.44e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNAS—hypertension	1.43e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—hypertension	1.43e-05	0.00012	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3R1—hypertension	1.43e-05	0.00012	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PDGFB—hypertension	1.42e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCE—hypertension	1.41e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGFR1—hypertension	1.41e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LPL—hypertension	1.41e-05	0.000119	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOB—hypertension	1.4e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTK2—hypertension	1.4e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—H2AFX—hypertension	1.4e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RPS6KB1—hypertension	1.4e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PDGFRB—hypertension	1.4e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PDGFA—hypertension	1.4e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VAV3—hypertension	1.4e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—hypertension	1.39e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HIF1A—hypertension	1.39e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGT—hypertension	1.38e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EDN1—hypertension	1.38e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADCY5—hypertension	1.38e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFBR2—hypertension	1.38e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL5—hypertension	1.37e-05	0.000115	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCG—hypertension	1.37e-05	0.000115	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNB3—hypertension	1.36e-05	0.000115	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CALM1—hypertension	1.36e-05	0.000115	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ITGB3—hypertension	1.36e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCA—hypertension	1.36e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LEP—hypertension	1.36e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—hypertension	1.36e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—YWHAZ—hypertension	1.35e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AVP—hypertension	1.34e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CAV1—hypertension	1.34e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LPL—hypertension	1.34e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOA1—hypertension	1.34e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SPP1—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGF—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—RHOA—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—H2AFX—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PDGFRB—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RPS6KB1—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KDR—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNAS—hypertension	1.33e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3R1—hypertension	1.32e-05	0.000111	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADCY5—hypertension	1.31e-05	0.00011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCG—hypertension	1.3e-05	0.00011	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOB—hypertension	1.3e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCD—hypertension	1.3e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCR5—hypertension	1.3e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ITGB3—hypertension	1.3e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCA—hypertension	1.3e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTK2—hypertension	1.29e-05	0.000109	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—hypertension	1.29e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—YWHAZ—hypertension	1.28e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—F2—hypertension	1.28e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCB—hypertension	1.28e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FN1—hypertension	1.28e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EDN1—hypertension	1.28e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—hypertension	1.27e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SPP1—hypertension	1.27e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGF—hypertension	1.27e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL5—hypertension	1.27e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—C3—hypertension	1.27e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—hypertension	1.26e-05	0.000106	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOTCH1—hypertension	1.25e-05	0.000105	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LPL—hypertension	1.24e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR5—hypertension	1.24e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCD—hypertension	1.24e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PDGFB—hypertension	1.23e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—H2AFX—hypertension	1.23e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PDGFRB—hypertension	1.23e-05	0.000103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RPS6KB1—hypertension	1.23e-05	0.000103	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGFR1—hypertension	1.23e-05	0.000103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADCY5—hypertension	1.22e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HIF1A—hypertension	1.21e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—hypertension	1.21e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—C3—hypertension	1.21e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCG—hypertension	1.21e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGT—hypertension	1.21e-05	0.000101	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ITGB3—hypertension	1.2e-05	0.000101	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCA—hypertension	1.2e-05	0.000101	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—YWHAZ—hypertension	1.19e-05	0.0001	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CALM1—hypertension	1.19e-05	9.97e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LEP—hypertension	1.18e-05	9.94e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—hypertension	1.18e-05	9.94e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SPP1—hypertension	1.18e-05	9.89e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGF—hypertension	1.18e-05	9.89e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PDGFB—hypertension	1.18e-05	9.89e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CAV1—hypertension	1.17e-05	9.84e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—hypertension	1.17e-05	9.84e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGFR1—hypertension	1.17e-05	9.84e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOA1—hypertension	1.17e-05	9.82e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—hypertension	1.17e-05	9.81e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INS—hypertension	1.16e-05	9.75e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KDR—hypertension	1.16e-05	9.73e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HIF1A—hypertension	1.15e-05	9.69e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGT—hypertension	1.15e-05	9.65e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR5—hypertension	1.14e-05	9.62e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCD—hypertension	1.14e-05	9.62e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL2—hypertension	1.14e-05	9.59e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CALM1—hypertension	1.13e-05	9.49e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LEP—hypertension	1.12e-05	9.46e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—hypertension	1.12e-05	9.46e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—hypertension	1.12e-05	9.43e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT2—hypertension	1.12e-05	9.42e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—hypertension	1.12e-05	9.41e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—C3—hypertension	1.12e-05	9.4e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—EGFR—hypertension	1.12e-05	9.38e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CAV1—hypertension	1.11e-05	9.37e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCB—hypertension	1.11e-05	9.37e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FN1—hypertension	1.11e-05	9.37e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—F2—hypertension	1.11e-05	9.37e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOA1—hypertension	1.11e-05	9.35e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KDR—hypertension	1.1e-05	9.27e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOTCH1—hypertension	1.09e-05	9.17e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PDGFB—hypertension	1.09e-05	9.15e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGFR1—hypertension	1.08e-05	9.1e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HIF1A—hypertension	1.07e-05	8.96e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SERPINE1—hypertension	1.06e-05	8.96e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGT—hypertension	1.06e-05	8.93e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—F2—hypertension	1.06e-05	8.92e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FN1—hypertension	1.06e-05	8.92e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCB—hypertension	1.06e-05	8.92e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CALM1—hypertension	1.04e-05	8.78e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—hypertension	1.04e-05	8.75e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LEP—hypertension	1.04e-05	8.75e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOTCH1—hypertension	1.04e-05	8.73e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CAV1—hypertension	1.03e-05	8.67e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGF2—hypertension	1.03e-05	8.67e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOA1—hypertension	1.03e-05	8.65e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RHOA—hypertension	1.03e-05	8.64e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KDR—hypertension	1.02e-05	8.57e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3R1—hypertension	1.02e-05	8.55e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOS3—hypertension	1.02e-05	8.55e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—hypertension	1.01e-05	8.54e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INS—hypertension	1.01e-05	8.49e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL2—hypertension	9.93e-06	8.35e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCB—hypertension	9.81e-06	8.25e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—F2—hypertension	9.81e-06	8.25e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FN1—hypertension	9.81e-06	8.25e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—hypertension	9.76e-06	8.21e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT2—hypertension	9.75e-06	8.2e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—EGFR—hypertension	9.71e-06	8.17e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—hypertension	9.66e-06	8.12e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INS—hypertension	9.61e-06	8.08e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOTCH1—hypertension	9.6e-06	8.08e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RELA—hypertension	9.57e-06	8.05e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL2—hypertension	9.45e-06	7.95e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MTOR—hypertension	9.38e-06	7.89e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—hypertension	9.29e-06	7.82e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT2—hypertension	9.28e-06	7.81e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SERPINE1—hypertension	9.27e-06	7.8e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—EGFR—hypertension	9.24e-06	7.78e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—hypertension	9.02e-06	7.59e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF2—hypertension	8.97e-06	7.55e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RHOA—hypertension	8.94e-06	7.52e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—hypertension	8.94e-06	7.52e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INS—hypertension	8.89e-06	7.48e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3R1—hypertension	8.85e-06	7.44e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOS3—hypertension	8.85e-06	7.44e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SERPINE1—hypertension	8.82e-06	7.42e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL2—hypertension	8.74e-06	7.36e-05	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—hypertension	8.71e-06	7.33e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—hypertension	8.6e-06	7.23e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT2—hypertension	8.59e-06	7.23e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—hypertension	8.57e-06	7.21e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—EGFR—hypertension	8.55e-06	7.2e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF2—hypertension	8.54e-06	7.18e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RHOA—hypertension	8.51e-06	7.16e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOS3—hypertension	8.42e-06	7.09e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3R1—hypertension	8.42e-06	7.09e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RELA—hypertension	8.33e-06	7.01e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MTOR—hypertension	8.17e-06	6.87e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SERPINE1—hypertension	8.16e-06	6.87e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—hypertension	8.16e-06	6.86e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1A—hypertension	8.13e-06	6.84e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTEN—hypertension	8.11e-06	6.82e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK8—hypertension	7.93e-06	6.67e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RELA—hypertension	7.93e-06	6.67e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—hypertension	7.91e-06	6.65e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF2—hypertension	7.9e-06	6.65e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RHOA—hypertension	7.88e-06	6.62e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—hypertension	7.85e-06	6.6e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOS3—hypertension	7.79e-06	6.56e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3R1—hypertension	7.79e-06	6.56e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MTOR—hypertension	7.78e-06	6.54e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EP300—hypertension	7.73e-06	6.5e-05	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—hypertension	7.58e-06	6.38e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SRC—hypertension	7.52e-06	6.33e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—hypertension	7.47e-06	6.29e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—hypertension	7.46e-06	6.28e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RELA—hypertension	7.34e-06	6.17e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—hypertension	7.32e-06	6.16e-05	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—hypertension	7.22e-06	6.07e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MTOR—hypertension	7.19e-06	6.05e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—hypertension	7.1e-06	5.98e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—hypertension	7.1e-06	5.97e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1A—hypertension	7.07e-06	5.95e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTEN—hypertension	7.06e-06	5.94e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—hypertension	6.91e-06	5.82e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK8—hypertension	6.91e-06	5.81e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—hypertension	6.89e-06	5.79e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—hypertension	6.76e-06	5.68e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—hypertension	6.74e-06	5.67e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1A—hypertension	6.73e-06	5.66e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EP300—hypertension	6.73e-06	5.66e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—hypertension	6.72e-06	5.65e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTEN—hypertension	6.72e-06	5.65e-05	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—hypertension	6.68e-06	5.62e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGFR—hypertension	6.59e-06	5.54e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—hypertension	6.57e-06	5.53e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK8—hypertension	6.57e-06	5.53e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—hypertension	6.55e-06	5.51e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SRC—hypertension	6.55e-06	5.51e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EP300—hypertension	6.41e-06	5.39e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—hypertension	6.38e-06	5.36e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—hypertension	6.25e-06	5.26e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1A—hypertension	6.23e-06	5.24e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SRC—hypertension	6.23e-06	5.24e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTEN—hypertension	6.22e-06	5.23e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK8—hypertension	6.08e-06	5.12e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—hypertension	6.07e-06	5.1e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—hypertension	6.06e-06	5.1e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EP300—hypertension	5.93e-06	4.99e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—hypertension	5.87e-06	4.93e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—hypertension	5.85e-06	4.92e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SRC—hypertension	5.77e-06	4.85e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGFR—hypertension	5.74e-06	4.83e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—hypertension	5.62e-06	4.72e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—hypertension	5.58e-06	4.7e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—hypertension	5.57e-06	4.69e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—hypertension	5.53e-06	4.65e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGFR—hypertension	5.46e-06	4.59e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—hypertension	5.17e-06	4.35e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—hypertension	5.15e-06	4.34e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—hypertension	5.07e-06	4.26e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGFR—hypertension	5.05e-06	4.25e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—hypertension	4.82e-06	4.05e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—hypertension	4.67e-06	3.93e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—hypertension	4.59e-06	3.86e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—hypertension	4.41e-06	3.71e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—hypertension	4.24e-06	3.57e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—hypertension	4.2e-06	3.53e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—hypertension	4.07e-06	3.42e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—hypertension	3.88e-06	3.27e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—hypertension	3.87e-06	3.26e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—hypertension	3.58e-06	3.01e-05	CbGpPWpGaD
